| abstract |
The present invention relates to a method for identifying a novel medical indication of a pharmaceutically active compound. The invention further provides novel medical indications for several pharmaceutically active compounds. Specifically, compounds are provided for the prevention and treatment of a disease or disorder treatable with a serotonin- norepinephrine reuptake inhibitor (SNRI), a serotonin receptor antagonist, an estazolam, a dopamine receptor antagonist, a dopamine receptor agonist, an L-type calcium channel blocker, a selective estrogen receptor modulator (SERM), an antihistamine. Also provided is a pharmaceutically active compound for the prevention or treatment of tachycardia. |